Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.

Background: Cognitive impairment is one of the most frequent and disabling non-motor symptoms in Parkinson disease (PD) and encompasses a continuum from mild cognitive impairment (PD-MCI) to dementia (PDD). The risk factors associated with them are not completely elucidated. Objective: To characterize the presence and clinical presentation of PD-MCI and PDD in patients with idiopathic PD, examining motor and non-motor features and determining factors associated with cognitive impairment. Methods: Multicenter, cross-sectional study in 298 PD patients who underwent clinical [Hoehn and Yahr (HY) staging and Clinical Impression of Severity Index for Parkinson Disease], neurological [Scales for Outcomes in Parkinson's Disease (SCOPA)-Motor], neuropsychological (Mini Mental State Examination, SCOPA-Cognition, Frontal Assessment Battery and Clinical Dementia Rating Scale), neuropsychiatric [SCOPA-Psychiatric complications, SCOPA-Psychosocial (SCOPA-PS), and Hospital Anxiety and Depression Scale (HADS)], and health-related quality of life [Parkinson Disease Questionnaire for quality of life (PDQ-8)] assessment. Movement Disorders Society criteria were applied to classify patients as normal cognition (NC), PD-MCI, and PDD. The association between variables was explored using multivariate binary and multinomial logistic regression models. Results: Seventy-two patients (24.2%) were classified as NC, 82 (27.5%) as PD-MCI, and 144 (48.3%) as PDD. These last two groups reported more psychosocial problems related with the disease (mean SCOPA-PS, 16.27 and 10.39, respectively), compared with NC (7.28) and lower quality-of-life outcomes (PDQ-8 48.98 and 28.42, respectively) compared to NC (19.05). The logistic regression analysis showed that both cognitive impaired groups had a more severe stage of PD measured by HY [odds ratio (OR) for MCI-PD, 2.45; 95% confidence interval (CI), 1.22-4.90; OR for PDD 2.64; 95% CI, 1.17-5.98]. Specifically, age (OR, 1.30; 95% CI, 1.16-1.47), years of education (OR, 0.91; 95% CI, 0.83-0.99), disease duration (OR, 1.19; 95% CI, 1.07-1.32), HADS-D (OR, 1.20; 95% CI, 1.06-1.35), and hallucinations (OR, 2.98; 95% CI, 1.16-7.69) were related to PDD. Conclusions: Cognitive impairment in PD is associated with more severe disease stage, resulting in a global, neuropsychiatric, psychosocial, and quality-of-life deterioration. This study provides a better understanding of the great impact that cognitive impairment has within the natural history of PD and its relationship with the rest of motor and non-motor symptoms in the disease.

Propiedades psicometricas del Cuestionario de Apoyo Social Funcional y de la Escala de Soledad en adultos mayores no institucionalizados en Espana / Psychometric properties of the Functional Social Support Questionnaire and the Loneliness Scale in non-institutionalized older adults in Spain

Objetivos Este estudio analiza las propiedades psicometricas del Cuestionario de Apoyo Social Funcional Duke-UNC (DUFSS, Duke-UNC Questionnaire of Functional Social Support) y de la Escala de Soledad de De Jong-Gierveld en una muestra de adultos mayores no institucionalizados. Métodos Muestra de 1106 adultos mayores no institucionalizados incluidos en una encuesta nacional sobre calidad de vida. Ambas escalas se analizaron segun la teoria clasica de los tests (aceptabilidad, consistencia interna, validez interna, validez convergente, validez discriminativa y precision) y analisis Rasch. Resultados Las puntuaciones medias (..) (AU)

Objectives To examine the psychometric properties of the Social Support Questionnaire Duke-UNC (DUFSS) and the De Jong-Gierveld Loneliness Scale in a sample of non-institutionalized older adults. Methods The sample consisted of 1,106 non-institutionalized older adults included in a national survey on quality of life. Both scales were analyzed according to classical test theory (acceptability, internal consistency, internal validity, convergent validity, discriminant validity and accuracy) and Rasch analysis. Results The mean ± standard deviation scores were 44.95 ± 8.9 for the DUFSS and 1.92 ± 1.83 for the Loneliness Scale. Cronbach's alpha was 0.94 for the DUFSS and 0.77 for the Loneliness Scale. Factor analysis identified two factors in each scale (explained variance: 73.8% for the DUFSS and 67.7% for the Loneliness Scale). The instruments showed a correlation of -0.59 with each other. Rasch analysis of the DUFSS identified two dimensions with a good model fit, whereas the Loneliness Scale did not fit the Rasch model. Conclusions The DUFSS, with some modifications, meets the Rasch assumptions and provides linear measures. However, more Rasch analysis studies are needed for the Loneliness Scale. According to classical test theory, the DUFSS has good internal consistency for comparisons among people and the Loneliness Scale for comparisons among groups. Both scales have satisfactory construct validity (AU)

Consciencia de disfagia en la enfermedad de Parkinson / Awareness of dysphagia in Parkinson's disease

Introducción y objetivo. Con el fin de evaluar el nivel de consciencia de los trastornos de la deglución en la enfermedad de Parkinson (EP), se ha diseñado y validado un cuestionario específico, el Dysphapark. Pacientes y métodos. Un total de 470 afectados de EP han respondido a la pregunta de si creen que tienen o no problemas de deglución, y seguidamente han cumplimentado un cuestionario autoadministrado que valora la eficacia y seguridad de la deglución. Se validó el Dysphapark a través del análisis de Rasch y métodos psicométricos clásicos. Resultados. Las dimensiones de seguridad y eficacia del Dysphapark muestran un buen ajuste al modelo de Rasch. La dimensión eficacia mostró diferencias significativas por género, duración de la enfermedad, consciencia de disfagia y duración de las comidas; la dimensión seguridad, por duración y gravedad de la enfermedad, consciencia de disfagia, logoterapia y conocimiento de espesante. A pesar de que un 90% de los pacientes tenía problemas de eficacia y seguridad en la deglución, un 79,45% no era consciente de padecer disfagia. Conclusiones. El cuestionario Dysphapark es una medida adecuada de la disfagia en EP, según el análisis de Rasch. Una alta proporción de pacientes con EP tiene disfagia, observándose una baja consciencia de la condición, de las consecuencias que puede tener y de la posibilidad de usar espesante. Dado que algunos de los trastornos de la deglución en la EP son asintomáticos y que existe una baja consciencia del trastorno, es recomendable incluir cuestionarios específicos, así como valoración clínica e instrumental de la disfagia en la práctica clínica

Introduction and aim. In order to be able to assess the level of awareness of swallowing disorders in Parkinson’s disease (PD), a specific questionnaire was designed and validated: the Dysphapark questionnaire. Patients and methods. A total of 470 persons with PD were asked whether they believe they have problems swallowing or not, and then they filled in a self-administered questionnaire that evaluates the effectiveness and safety of swallowing. The Dysphapark questionnaire was validated by means of Rasch analysis and classical psychometric methods. Results. The safety and effectiveness dimensions of the Dysphapark fit the Rasch model well. The efficacy dimensionshowed significant differences for gender, length of the illness, awareness of dysphagia and length of meals. Significant differences were also found in the safety dimension for length and severity of illness, awareness of dysphagia, speech therapy and knowledge of thickening agents. Despite the fact that 90% of patients had problems concerning effectiveness and safety in swallowing, 79.45% were not aware that they suffered from dysphagia. Conclusions. The Dysphapark questionnaire is a suitable measure of dysphagia in PD, according to the Rasch analysis. A high proportion of patients with PD have dysphagia, although it has been observed that they have a low level of awareness of the condition, of the consequences it may have and of the possibility of using thickening agents. Given that some of the swallowing disorders in PD are asymptomatic and that the level of awareness of the disorder is low, we recommend including specific questionnaires as well as clinical and instrumental evaluation of dysphagia in clinical practice

[Awareness of dysphagia in Parkinson's disease]. / Consciencia de disfagia en la enfermedad de Parkinson.

INTRODUCTION AND AIM: In order to be able to assess the level of awareness of swallowing disorders in Parkinson's disease (PD), a specific questionnaire was designed and validated: the Dysphapark questionnaire. PATIENTS AND METHODS: A total of 470 persons with PD were asked whether they believe they have problems swallowing or not, and then they filled in a self-administered questionnaire that evaluates the effectiveness and safety of swallowing. The Dysphapark questionnaire was validated by means of Rasch analysis and classical psychometric methods. RESULTS: The safety and effectiveness dimensions of the Dysphapark fit the Rasch model well. The efficacy dimension showed significant differences for gender, length of the illness, awareness of dysphagia and length of meals. Significant differences were also found in the safety dimension for length and severity of illness, awareness of dysphagia, speech therapy and knowledge of thickening agents. Despite the fact that 90% of patients had problems concerning effectiveness and safety in swallowing, 79.45% were not aware that they suffered from dysphagia. CONCLUSIONS: The Dysphapark questionnaire is a suitable measure of dysphagia in PD, according to the Rasch analysis. A high proportion of patients with PD have dysphagia, although it has been observed that they have a low level of awareness of the condition, of the consequences it may have and of the possibility of using thickening agents. Given that some of the swallowing disorders in PD are asymptomatic and that the level of awareness of the disorder is low, we recommend including specific questionnaires as well as clinical and instrumental evaluation of dysphagia in clinical practice.

[Validation of the functional independence scale]. / Validación de la Escala de Independencia Funcional.

OBJECTIVE: To assess the psychometric quality of an instrument designed to measure functional independence (Functional Independence Scale [FIS]) in several activities of daily living domains and to be applied by trained non-health-related interviewers. The study was carried out in the autonomous region of Madrid in community-dwelling elders. METHODS: We performed a cross-sectional validation study. In addition to the FIS, Pfeiffer's questionnaire, the Depression Subscale of the Hospital Anxiety and Depression Scale, the Comorbidity Index, the Barthel Index, and EQ-5D were used. These measures were cross-sectionally applied to community-dwelling elders (n=500) and outpatients in a general hospital (n=100) aged 65 years. The following FIS psychometric attributes were analyzed: acceptability, scaling assumptions, internal consistency, construct validity, and precision. RESULTS: A fully computable FIS total score was obtained in 94.3% of the subjects. A ceiling effect (60.65%), but no floor effect (0.22%) was evident in the community-dwelling elders. No floor or ceiling effects were detected in the hospital sample. Scaling assumptions and internal consistency were satisfactory (item-total correlations: 0.57-0.91; Cronbach's alpha: 0.94). Factor analysis identified three factors that explained 74.3% of the variance. Indexes of convergent, internal, and known-groups validity were satisfactory. The scale's precision, determined by the standard error of measurement (2.49; 95%CI=4.88), was also satisfactory. CONCLUSION: The FIS is an easy-to-use instrument with appropriate metric attributes. This scale can be usefully applied in broad samples of non-institutionalized elders by non-health related personnel.

Validación de la Escala de Independencia Funcional / Validation of the Functional Independence Scale

Objetivo: Evaluar la calidad psicométrica de un instrumento diseñado para medir la independencia funcional (Escala de Independencia Funcional, EIF) en varios dominios de actividades de la vida diaria y ser aplicado por entrevistadores entrenados no expertos en el ámbito sanitario. El estudio se realizó en población mayor no institucionalizada residente en la Comunidad de Madrid. Métodos: Estudio transversal de validación. Se aplicaron la EIF, el test de Pfeiffer, la subescala de depresión de la Hospital Anxiety and Depression Scale, un indicador de comorbilidad, el Índice de Barthel y el EQ-5D, a población residente en medio comunitario (n=500) y a pacientes ambulatorios en medio hospitalario (n=100) de edad ≥65 años. Se analizaron los siguientes atributos psicométricos de la EIF: aceptabilidad, asunciones escalares, consistencia interna, validez de constructo y precisión. Resultados: La escala resultó totalmente computable en el 94,3% de los sujetos, con efecto techo (60,65%) y sin efecto suelo (0,22%) en el medio comunitario. En el medio hospitalario no se evidenció efecto suelo ni techo. La escala mostró asunciones escalares satisfactorias y elevada consistencia interna (correlaciones ítem-total: 0,57¿0,91; alfa de Cronbach: 0,94), así como una estructura multidimensional (tres factores; 74,3% de la varianza). Los índices de validez convergente, interna y para grupos conocidos, al igual que la precisión (error estándar de la medida: 2,49; intervalo de confianza del 95%: 4,88) resultaron satisfactorios. Conclusiones: En suma, la EIF es una escala de uso sencillo con atributos métricos apropiados, y su aplicación por parte de personal no sanitario resulta útil para muestras amplias de individuos mayores no institucionalizados(AU)

Objective: To assess the psychometric quality of an instrument designed to measure functional independence (Functional Independence Scale [FIS]) in several activities of daily living domains and to be applied by trained non-health-related interviewers. The study was carried out in the autonomous region of Madrid in community-dwelling elders. Methods: We performed a cross-sectional validation study. In addition to the FIS, Pfeiffer's questionnaire, the Depression Subscale of the Hospital Anxiety and Depression Scale, the Comorbidity Index, the Barthel Index, and EQ-5D were used. These measures were cross-sectionally applied to community-dwelling elders (n=500) and outpatients in a general hospital (n=100) aged ≥65 years. The following FIS psychometric attributes were analyzed: acceptability, scaling assumptions, internal consistency, construct validity, and precision. Results: A fully computable FIS total score was obtained in 94.3% of the subjects. A ceiling effect (60.65%), but no floor effect (0.22%) was evident in the community-dwelling elders. No floor or ceiling effects were detected in the hospital sample. Scaling assumptions and internal consistency were satisfactory (item-total correlations: 0.57¿0.91; Cronbach's alpha: 0.94). Factor analysis identified three factors that explained 74.3% of the variance. Indexes of convergent, internal, and known-groups validity were satisfactory. The scale's precision, determined by the standard error of measurement (2.49; 95%CI=4.88), was also satisfactory. Conclusion: The FIS is an easy-to-use instrument with appropriate metric attributes. This scale can be usefully applied in broad samples of non-institutionalized elders by non-health related personnel(AU)